Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이한아 | * |
dc.date.accessioned | 2022-08-11T16:30:59Z | - |
dc.date.available | 2022-08-11T16:30:59Z | - |
dc.date.issued | 2022 | * |
dc.identifier.issn | 1471-230X | * |
dc.identifier.other | OAK-31913 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/262283 | - |
dc.description.abstract | Background/Aims: We retrospectively compared the effect of endoscopic variceal obturation (EVO) and retrograde transvenous obliteration (RTO) in acute cardiofundal variceal bleeding. Methods: Patients with acute cardiofundal variceal bleeding treated with EVO or RTO at two hospitals were included. Results: Ninety patients treated with EVO and 86 treated with RTO were analyzed. The mean model for end-stage liver disease score was significantly higher in EVO group than in RTO group (13.5 vs. 11.7, P = 0.016). The bleeding control rates were high (97.8% vs. 96.5%), and the treatment-related complication rates were low in both EVO and RTO groups (2.2% vs. 3.5%). During the median follow-up of 18.0 months, gastric variceal (GV) and esophageal variceal rebleeding occurred in 34 (19.3%) and 7 (4.0%) patients, respectively. The all-variceal rebleeding rates were comparable between EVO and RTO groups (32.4% vs. 20.8% at 2-year, P = 0.150), while the GV rebleeding rate was significantly higher in EVO group than in RTO group (32.4% vs. 12.8% at 2-year, P = 0.003). On propensity score-matched analysis (71 patients in EVO vs. 71 patients in RTO group), both all-variceal and GV rebleeding rates were significantly higher in EVO group than in RTO group (all P < 0.05). In Cox regression analysis, EVO (vs. RTO) was the only significant predictor of higher GV rebleeding risk (hazard ratio 3.132, P = 0.005). The mortality rates were similar between two groups (P = 0.597). Conclusions: Both EVO and RTO effectively controlled acute cardiofundal variceal bleeding. RTO was superior to EVO in preventing all-variceal and GV rebleeding after treatment, with similar survival outcomes. © 2022, The Author(s). | * |
dc.language | English | * |
dc.publisher | BioMed Central Ltd | * |
dc.subject | Balloon-occluded retrograde transvenous obliteration | * |
dc.subject | Portal hypertension | * |
dc.subject | Prevention | * |
dc.subject | Rebleeding | * |
dc.subject | Vascular plug-assisted retrograde transvenous obliteration | * |
dc.title | Endoscopic variceal obturation and retrograde transvenous obliteration for acute gastric cardiofundal variceal bleeding in liver cirrhosis | * |
dc.type | Article | * |
dc.relation.issue | 1 | * |
dc.relation.volume | 22 | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.journaltitle | BMC Gastroenterology | * |
dc.identifier.doi | 10.1186/s12876-022-02428-1 | * |
dc.identifier.wosid | WOS:000830709500001 | * |
dc.identifier.scopusid | 2-s2.0-85134755805 | * |
dc.author.google | Lee H.A. | * |
dc.author.google | Kwak J. | * |
dc.author.google | Cho S.B. | * |
dc.author.google | Lee Y.-S. | * |
dc.author.google | Jung Y.K. | * |
dc.author.google | Kim J.H. | * |
dc.author.google | Kim S.U. | * |
dc.author.google | An H. | * |
dc.author.google | Yim H.J. | * |
dc.author.google | Yeon J.E. | * |
dc.author.google | Seo Y.S. | * |
dc.contributor.scopusid | 이한아(57190980926;5831162710) | * |
dc.date.modifydate | 20240311134944 | * |